BioDelivery Sciences International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDSI research report →
About the company
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies.
- CEO
- Herm Cukier
- IPO
- 2002
- Employees
- 200
- HQ
- Raleigh, NC, US
Price Chart
- Market Cap
- $577.05M
- P/E
- 6.80
- P/S
- 3.46
- P/B
- 3.07
- EV/EBITDA
- 11.71
- Div Yield
- 0.00%
- Gross Margin
- 85.98%
- Op Margin
- 22.27%
- Net Margin
- 50.90%
- ROE
- 57.33%
- ROIC
- 15.04%
- Revenue
- $166.70M · 6.54%
- Net Income
- $84.86M · 230.05%
- EPS
- $0.82 · 215.38%
- Op Income
- $37.12M
- FCF YoY
- 62.70%
- 52W High
- $5.62
- 52W Low
- $2.50
- 50D MA
- $4.96
- 200D MA
- $3.88
- Beta
- 0.00
- Avg Volume
- 3.35M
Get TickerSpark's AI analysis on BDSI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 22, 22 | Watson W. Mark | sell | 54,740 |
| Mar 22, 22 | Watson W. Mark | other | 90,663 |
| Mar 22, 22 | Vollins James | sell | 282,055 |
| Mar 22, 22 | Vollins James | sell | 269,244 |
| Mar 22, 22 | Vollins James | sell | 43,334 |
| Mar 22, 22 | Vollins James | sell | 29,826 |
| Mar 22, 22 | Vollins James | sell | 82,508 |
| Mar 22, 22 | Vollins James | sell | 91,401 |
| Mar 22, 22 | Singh Vanila | sell | 17,019 |
| Mar 22, 22 | Singh Vanila | other | 35,851 |
Our BDSI coverage
Recent articles, reports, and earnings notes.
No research on BDSI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BDSI report →Similar companies
Peers in the same neighborhood.